The oral protein-kinase C β inhibitor enzastaurin (LY317615) suppresses signalling through the AKT pathway, inhibits proliferation and induces apoptosis in multiple myeloma cell lines.

Saved in:
Bibliographic Details
Title: The oral protein-kinase C β inhibitor enzastaurin (LY317615) suppresses signalling through the AKT pathway, inhibits proliferation and induces apoptosis in multiple myeloma cell lines.
Authors: Neri, Antonino1,2 (AUTHOR), Marmiroli, Sandra3 (AUTHOR), Tassone, Pierfrancesco4 (AUTHOR), Lombardi, Luigia1 (AUTHOR), Nobili, Lucia2 (AUTHOR), Verdelli, Donata1 (AUTHOR), Civallero, Monica5 (AUTHOR), Cosenza, Maria5 (AUTHOR), Bertacchini, Jessika3 (AUTHOR), Federico, Massimo5 (AUTHOR), De Pol, Anto3 (AUTHOR), Deliliers, Giorgio Lambertenghi2 (AUTHOR), Sacchi, Stefano5 (AUTHOR) lbsacchi@unimo.it
Source: Leukemia & Lymphoma. Jul2008, Vol. 49 Issue 7, p1374-1383. 10p. 2 Black and White Photographs, 3 Charts, 3 Graphs.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:10428194
DOI:10.1080/10428190802078289